Hypothesis

Aged photoreceptors accumulate intracellular lipid droplets that physically sequester ATG9, a key autophagy initiation factor, thereby blocking phagophore expansion and maintaining autophagy in a suppressed state. This mechanism operates independently of, yet synergizes with, the known Rubicon‑mediated VPS34 inhibition and mTORC1 reactivation, providing a lipid‑based checkpoint that prevents premature degradation of long‑lived proteins and lipids that have become structurally abnormal but non‑toxic.

Mechanistic rationale

1. Lipid droplet expansion with age – Oxidative stress and impaired β‑oxidation drive triglyceride storage in photoreceptor inner segments, as shown by increased perilipin‑2 (PLIN2) staining in old mouse retina 1.
2. ATG9 affinity for phospholipid‑rich surfaces – ATG9 cycles between the trans‑Golgi network and endosomes, recycling phospholipids to nascent phagophores. In vitro work demonstrates that ATG9 binds preferentially to curved phosphatidyl‑ethanolamine‑rich membranes, a property mimicked by the phospholipid monolayer of lipid droplets 2.
3. Sequestration model – When lipid droplet surface area expands, ATG9 becomes trapped on these droplets, reducing its availability for phagophore formation. Consequently, LC3 lipidation stalls despite normal ATG3/ATG7 activity, explaining the observed block at the elongation step without requiring oxidative inhibition of those ATGs.
4. Feedback to mTORC1 – Lipid‑droplet‑bound ATG9 fails to deliver amino acids to the lysosomal surface, sustaining Rag‑GTPase activation and mTORC1 signaling, which further suppresses ULK1 complex activity 3.
5. Reversibility – Acute depletion of lipid droplets using DGAT1 inhibitor A922500 restores ATG9 mobility and autophagic flux in aged rat liver, mirroring the plasma‑young rescue effect 4.

Testable predictions

• Prediction 1: In aged mouse retina, immunofluorescence will show increased colocalization of ATG9 with PLIN2‑positive lipid droplets compared with young tissue.
• Prediction 2: Genetic knockdown of PLIN2 or pharmacological inhibition of DGAT1 in aged mice will increase ATG9 diffusion (measured by FRAP) and elevate LC3‑II levels without altering Rubicon expression.
• Prediction 3: Expressing a lipid‑droplet‑targeting deficient ATG9 mutant (ΔAML domain) in aged photoreceptors will rescue autophagy flux and improve photoreceptor survival under oxidative stress, whereas wild‑type ATG9 overexpression will not.
• Prediction 4: Chronic lipid‑droplet accumulation will correlate with sustained mTORC1 activity (p‑S6K) in the same cells, and dual targeting (DGAT1 inhibition + rapamycin) will produce additive autophagy restoration.

Implications

If validated, this hypothesis reframes autophagy decline as a lipid‑homeostasis checkpoint that preserves a fragile proteolipid landscape in non‑dividing neurons. It suggests that therapeutic strategies targeting lipid droplet biogenesis—not only canonical mTOR or Rubicon pathways—could re‑activate autophagy in age‑related retinal degeneration and potentially other post‑mitotic tissues.